Tirzepatide (Mounjaro, Zepbound), a dual GIP/GLP-1 receptor agonist, is substantially eliminated from the body within 23 weeks of discontinuation
Maintaining a stable storage environment helps ensure the medication remains safe and effective for the recommended period
Consider a probiotic supplement to support gut health
Neurological causes, such as migraines, are treated with triptans, CGRP antagonists, or prophylactic agents depending on frequency and severity
Rothaus or our Medical Aesthetician, Juliana
Also, Nooms robust GLP-1 support enables clinical care and a personalized healthy habit and coaching program